Fig. 4From: siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapyThe influence of E6-siRNA combination with Oxaliplatin on the cell cycle. As a result of the siRNA with Oxaliplatin combination therapy and the knockdown of the E6 gene, the cell cycle is arrested in sub-G1 stageBack to article page